|
Volumn 46, Issue 8, 2002, Pages 2201-2206
|
The safety of celecoxib in patients with aspirin-sensitive asthma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CORTICOSTEROID;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
MONTELUKAST;
ZAFIRLUKAST;
ZILEUTON;
ABDOMINAL PAIN;
ANALGESIA;
ARTICLE;
ASTHMA;
CALCULATION;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE EXACERBATION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG CROSS REACTIVITY;
DRUG HYPERSENSITIVITY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
EYE DISEASE;
FEMALE;
FLUSHING;
FORCED EXPIRATORY VOLUME;
HUMAN;
IMMUNE RESPONSE;
LARYNX SPASM;
MAJOR CLINICAL STUDY;
MALE;
NOSE CONGESTION;
PRIORITY JOURNAL;
PROBABILITY;
PROVOCATION TEST;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
SINGLE BLIND PROCEDURE;
SYMPTOM;
URTICARIA;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASPIRIN;
ASTHMA;
CYCLOOXYGENASE INHIBITORS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG HYPERSENSITIVITY;
DRUG SYNERGISM;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PYRAZOLES;
SULFONAMIDES;
|
EID: 0036676087
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.10426 Document Type: Article |
Times cited : (138)
|
References (33)
|